Treatment of pregnant women with iron deficiency anemia

Mise à jour : Il y a 4 ans
Référence : EUCTR2017-000776-29

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of the trial is to evaluate and compare the effect of IV iron isomalto-side to a fixed dose of oral iron administered as tablet ferrous fumarate with ascorbic acid as correction of anaemia in pregnant women who have IDA after 4 weeks of standard treatment.


Critère d'inclusion

  • iron deficiency anaemia in pregnant women

Liens